3 days Ago By ABMN Staff
Schroder Investment Management Group reduced its holdings in shares of Waters Co. ( NYSE:WAT – Free Report ) by 19.1% in the fourth quarter, Holdings Channel reports.
The institutional investor owned 3,353 shares of the medical instruments supplier’s stock after selling 794 shares during the period. Schroder Investment Management Group’s holdings in Waters were worth $1,244,000 as of its most recent SEC filing. Other hedge funds and other institutional investors also recently made changes to their positions in the company.
Envestnet Portfolio Solutions Inc. boosted its stake in Waters by 15.5% during the 4th quarter.
Envestnet Portfolio Solutions Inc. now owns 3,587 shares of the medical instruments supplier’s stock valued at $1,331,000 after purchasing an additional 482 shares during the last quarter. Barclays PLC boosted its position in shares of Waters by 34.
8% during the third quarter. Barclays PLC now owns 159,995 shares of the medical instruments supplier’s stock valued at $57,579,000 after buying an additional 41,339 shares during the last quarter. Savant Capital LLC boosted its position in shares of Waters by 3.
8% during the fourth quarter. Savant Capital LLC now owns 1,704 shares of the medical instruments supplier’s stock valued at $632,000 after buying an additional 63 shares during the last quarter. Public Sector Pension Investment Board raised its position in Waters by 13.
2% in the 3rd quarter. Public Sector Pension Investment Board now owns 2,578 shares of the medical instruments supplier’s stock valued at $928,000 after buying an additional 300 shares during the last quarter. Finally, Robeco Institutional Asset Management B.
V. raised its position in Waters by 7.1% in the 4th quarter.
Robeco Institutional Asset Management B.V. now owns 421,691 shares of the medical instruments supplier’s stock valued at $156,439,000 after buying an additional 27,801 shares during the last quarter.
94.01% of the stock is owned by institutional investors. Analysts Set New Price Targets Several analysts have recently issued reports on the stock.
UBS Group upped their target price on shares of Waters from $405.00 to $410.00 and gave the stock a “neutral” rating in a research note on Thursday, February 13th.
StockNews.com lowered shares of Waters from a “buy” rating to a “hold” rating in a research note on Tuesday, February 25th. Scotiabank raised shares of Waters from a “sector perform” rating to a “sector outperform” rating and lifted their target price for the stock from $430.
00 to $450.00 in a research report on Thursday, February 13th. KeyCorp raised Waters from a “sector weight” rating to an “overweight” rating and set a $460.
00 price target for the company in a research report on Monday, March 31st. Finally, Baird R W upgraded Waters from a “hold” rating to a “strong-buy” rating in a report on Wednesday, March 26th. Ten equities research analysts have rated the stock with a hold rating, seven have given a buy rating and two have assigned a strong buy rating to the company’s stock.
According to data from MarketBeat, Waters presently has a consensus rating of “Moderate Buy” and an average target price of $401.31. Waters Trading Down 6.
0 % Shares of Waters stock opened at $324.57 on Monday. The stock has a market capitalization of $19.
28 billion, a P/E ratio of 30.30, a P/E/G ratio of 3.79 and a beta of 1.
04. Waters Co. has a 52-week low of $279.
24 and a 52-week high of $423.56. The company has a debt-to-equity ratio of 1.
14, a quick ratio of 0.65 and a current ratio of 0.94.
The stock’s 50-day simple moving average is $381.53 and its 200 day simple moving average is $373.74.
Waters ( NYSE:WAT – Get Free Report ) last posted its quarterly earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.
02 by $0.08. Waters had a net margin of 21.
56% and a return on equity of 46.31%. As a group, research analysts anticipate that Waters Co.
will post 12.86 EPS for the current year. Waters Company Profile ( Free Report ) Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe.
It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. Featured Articles Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for Waters Co. ( NYSE:WAT – Free Report ). Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.
com's FREE daily email newsletter ..
